Original Query: ALL
Previous Study | Return to List | Next Study
Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
|ClinicalTrials.gov Identifier: NCT00006077|
Recruitment Status : Completed
First Posted : August 7, 2000
Last Update Posted : March 4, 2008
National Institute of Neurological Disorders and Stroke (NINDS)
Information provided by:
National Institutes of Health Clinical Center (CC)
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Primary Completion Date :||No date given|
|Estimated Study Completion Date :||July 2003|
Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415-55.
Mizuno Y, Mori H, Kondo T. Parkinson's disease: from etiology to treatment. Intern Med. 1995 Nov;34(11):1045-54. Review.